1. Sustained-Release, Extended-Release, and Other Time-Release Formulations in Neuropsychiatry
2. Specific pharmacology of long‐acting, extended‐release, and sustained‐release opioids for the treatment of chronic nonmalignant pain;Sloan PA;J Opioid Manag,2015
3. FDA. FDA Guidance: Bioavailability and Bioequivalence Studies Submitted in NDAs or INDs—General Considerations.https://wwwfdagov/media/121311/download. Accessed April 29 2020.
4. FDA. FDA Guidance: Exposure‐Response Relationships—Study Design Data Analysis and Regulatory Applications.https://wwwfdagov/media/71277/download. Accessed August 24 2018.
5. FDA. FDA Guidance: Providing Clinical Evidence of Effectiveness for Human Drug and Biological Products.1998.https://www.fda.gov/media/71655/download. Accessed August 24 2018.